The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

Cylembio Plus Keytruda Extends PFS in Trial For Superior Melanoma

Knowledge present that the most cancers vaccine Cylembio plus Keytruda demonstrated scientific enchancment in progression-free survival in unresectable/superior melanoma.Topline knowledge from a pivotal...

Monetary and Instructional Disparities Persist in Glioblastoma Care

A nationwide survey of sufferers and caregivers has discovered instructional and monetary disparities in mind most cancers care: © inventory.adobe.com.A nationwide survey of...

Assist Program Affords Assist for Dad and mom Going through Pediatric Most cancers

Dena Paluck volunteers with Hopeful Hearts to attach mother and father of youngsters with most cancers to assist networks. Dena Paluck first discovered about...

Increasing Scientific Trial Entry for Sufferers With Kidney Most cancers

It is very important increase scientific trial entry for sufferers with kidney most cancers with a view to guarantee a consultant research inhabitants,...

Intensive Chemotherapy Boosts Survival in Sufferers With Superior MPNs

Intensive chemotherapy improved survival in sufferers with accelerated and blast section myeloproliferative neoplasms, with Venclexta displaying no clear profit. Picture generated by Google...

Hot Topics